Literature DB >> 26258265

Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.

Bethany Tellor1, Lee P Skrupky1, William Symons2, Eric High2, Scott T Micek1, John E Mazuski2.   

Abstract

BACKGROUND: Patients with intra-abdominal sepsis and associated bacteremia have a high mortality rate. However, outcomes studies in this population are limited, in part because of the small numbers of such patients. The objective of this study was to describe characteristics of critically ill patients with secondary blood stream infection (BSI) of intra-abdominal origin and identify predictors of mortality.
METHODS: This retrospective, single-center study evaluated patients admitted between January 2005 and January 2011 with bacteremia because of an intra-abdominal source. Patients were included if they met criteria for severe sepsis based on International Classification of Diseases, 9th Revision (ICD 9) codes for acute organ dysfunction, had a positive blood culture, had at least one ICD 9 code indicative of an intra-abdominal process, and had a confirmed or clinically suspected intra-abdominal infection (IAI) within 72 h of the blood culture. Chart review was performed to confirm the presence of these criteria and also the absence of any other potential source of bacteremia. Data were collected on patient demographics, BSI source, source control procedure details, microorganisms isolated, and antibiotics administered. Multivariable logistic regression analysis was performed to identify independent predictors of mortality.
RESULTS: Three hundred six patients with BSI were identified, of which 108 episodes were deemed to be of intra-abdominal origin. Gram-negative organisms comprised 43% of blood isolates, followed by gram-positives (33%), anaerobes (14%), and yeast (9%). Appropriate antimicrobial therapy was administered in 71% of patients. The overall mortality rate was 27.8%. As compared with survivors, non-survivors were older, more likely to have underlying COPD or asthma, and have renal or metabolic failure (p<0.05 for all). Among non-survivors, adequate source control was obtained less frequently (64% vs. 91%, p=0.002) and median time to appropriate antibiotics was longer (23 h vs. 4 h, p=0.004). Logistic regression analysis revealed inadequate source control (p=0.002) and inappropriate antibiotics (p=0.016) to be independently associated with mortality.
CONCLUSIONS: Critically ill patients with a BSI of abdominal origin are at high risk for mortality. Failure to achieve adequate source control and administration of inappropriate antibiotics were independent predictors of mortality. Thus, these represent potential opportunities to impact outcomes in patients with complicated IAI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26258265     DOI: 10.1089/sur.2014.166

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  28 in total

1.  Bacterial Proliferation May Be the Key Component of Sepsis Mortality.

Authors:  Christian de Tymowski; Mario D T Correia; Renato C Monteiro; Philippe Montravers; Sanae Ben Mkaddem
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

2.  Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay.

Authors:  Evgeny A Idelevich; Luise M Storck; Katrin Sparbier; Oliver Drews; Markus Kostrzewa; Karsten Becker
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 3.  Procalcitonin-guided antibiotic treatment in critically ill patients.

Authors:  Andreas Hohn; Bernhard Heising; Jan-Karl Schütte; Olaf Schroeder; Stefan Schröder
Journal:  Langenbecks Arch Surg       Date:  2016-06-10       Impact factor: 3.445

Review 4.  Current understanding in source control management in septic shock patients: a review.

Authors:  Leonel Lagunes; Belen Encina; Sergio Ramirez-Estrada
Journal:  Ann Transl Med       Date:  2016-09

5.  Damage control surgery in perforated diverticulitis: ongoing peritonitis at second surgery predicts a worse outcome.

Authors:  M A Sohn; A Agha; P Steiner; A Hochrein; M Komm; R Ruppert; P Ritschl; F Aigner; I Iesalnieks
Journal:  Int J Colorectal Dis       Date:  2018-03-13       Impact factor: 2.571

Review 6.  Can the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?

Authors:  John C Alverdy; Robert Keskey; Renee Thewissen
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

7.  Longer-Duration Antimicrobial Therapy Does Not Prevent Treatment Failure in High-Risk Patients with Complicated Intra-Abdominal Infections.

Authors:  Taryn E Hassinger; Christopher A Guidry; Ori D Rotstein; Therese M Duane; Heather L Evans; Charles H Cook; Patrick J O'Neill; John E Mazuski; Reza Askari; Lena M Napolitano; Nicholas Namias; Preston R Miller; E Patchen Dellinger; Raul Coimbra; Christine S Cocanour; Kaysie L Banton; Joseph Cuschieri; Kimberley Popovsky; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2017-06-26       Impact factor: 2.150

Review 8.  Abdominal Sepsis.

Authors:  Jan J De Waele
Journal:  Curr Infect Dis Rep       Date:  2016-08       Impact factor: 3.725

Review 9.  WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections.

Authors:  Massimo Sartelli; Federico Coccolini; Yoram Kluger; Ervis Agastra; Fikri M Abu-Zidan; Ashraf El Sayed Abbas; Luca Ansaloni; Abdulrashid Kayode Adesunkanmi; Boyko Atanasov; Goran Augustin; Miklosh Bala; Oussama Baraket; Suman Baral; Walter L Biffl; Marja A Boermeester; Marco Ceresoli; Elisabetta Cerutti; Osvaldo Chiara; Enrico Cicuttin; Massimo Chiarugi; Raul Coimbra; Elif Colak; Daniela Corsi; Francesco Cortese; Yunfeng Cui; Dimitris Damaskos; Nicola De' Angelis; Samir Delibegovic; Zaza Demetrashvili; Belinda De Simone; Stijn W de Jonge; Sameer Dhingra; Stefano Di Bella; Francesco Di Marzo; Salomone Di Saverio; Agron Dogjani; Therese M Duane; Mushira Abdulaziz Enani; Paola Fugazzola; Joseph M Galante; Mahir Gachabayov; Wagih Ghnnam; George Gkiokas; Carlos Augusto Gomes; Ewen A Griffiths; Timothy C Hardcastle; Andreas Hecker; Torsten Herzog; Syed Mohammad Umar Kabir; Aleksandar Karamarkovic; Vladimir Khokha; Peter K Kim; Jae Il Kim; Andrew W Kirkpatrick; Victor Kong; Renol M Koshy; Igor A Kryvoruchko; Kenji Inaba; Arda Isik; Katia Iskandar; Rao Ivatury; Francesco M Labricciosa; Yeong Yeh Lee; Ari Leppäniemi; Andrey Litvin; Davide Luppi; Gustavo M Machain; Ronald V Maier; Athanasios Marinis; Cristina Marmorale; Sanjay Marwah; Cristian Mesina; Ernest E Moore; Frederick A Moore; Ionut Negoi; Iyiade Olaoye; Carlos A Ordoñez; Mouaqit Ouadii; Andrew B Peitzman; Gennaro Perrone; Manos Pikoulis; Tadeja Pintar; Giuseppe Pipitone; Mauro Podda; Kemal Raşa; Julival Ribeiro; Gabriel Rodrigues; Ines Rubio-Perez; Ibrahima Sall; Norio Sato; Robert G Sawyer; Helmut Segovia Lohse; Gabriele Sganga; Vishal G Shelat; Ian Stephens; Michael Sugrue; Antonio Tarasconi; Joel Noutakdie Tochie; Matti Tolonen; Gia Tomadze; Jan Ulrych; Andras Vereczkei; Bruno Viaggi; Chiara Gurioli; Claudio Casella; Leonardo Pagani; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-09-25       Impact factor: 5.469

10.  Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella pneumoniae Bloodstream Infections.

Authors:  Feizhen Song; Kai Zhang; Jianjiang Huang; Zhenhua Qian; Hongwei Zhou; Jiachang Cai; Cheng Zheng; Feifei Zhou; Wei Cui; Gensheng Zhang
Journal:  Biomed Res Int       Date:  2021-06-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.